{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T10:26:41Z","timestamp":1787135201446,"version":"build-2736575974"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ganzhou Science and Technology Bureau Leading Talent Program","award":["(No. 2022CXRC9621)"],"award-info":[{"award-number":["(No. 2022CXRC9621)"]}]},{"name":"Ganzhou Science and Technology Bureau Leading Talent Program","award":["(No. 2022CXRC9621)"],"award-info":[{"award-number":["(No. 2022CXRC9621)"]}]},{"name":"Ganzhou Science and Technology Bureau Leading Talent Program","award":["(No. 2022CXRC9621)"],"award-info":[{"award-number":["(No. 2022CXRC9621)"]}]},{"name":"Ganzhou Science and Technology Bureau Leading Talent Program","award":["(No. 2022CXRC9621)"],"award-info":[{"award-number":["(No. 2022CXRC9621)"]}]},{"name":"Ganzhou Science and Technology Bureau Leading Talent Program","award":["(No. 2022CXRC9621)"],"award-info":[{"award-number":["(No. 2022CXRC9621)"]}]},{"name":"Ganzhou Science and Technology Bureau Leading Talent Program","award":["(No. 2022CXRC9621)"],"award-info":[{"award-number":["(No. 2022CXRC9621)"]}]},{"name":"Ganzhou Science and Technology Bureau Leading Talent Program","award":["(No. 2022CXRC9621)"],"award-info":[{"award-number":["(No. 2022CXRC9621)"]}]},{"name":"Ganzhou Science and Technology Bureau Leading Talent Program","award":["(No. 2022CXRC9621)"],"award-info":[{"award-number":["(No. 2022CXRC9621)"]}]},{"name":"Ganzhou Science and Technology Bureau Leading Talent Program","award":["(No. 2022CXRC9621)"],"award-info":[{"award-number":["(No. 2022CXRC9621)"]}]},{"name":"Ganzhou Science and Technology Bureau Leading Talent Program","award":["(No. 2022CXRC9621)"],"award-info":[{"award-number":["(No. 2022CXRC9621)"]}]},{"name":"Ganzhou Science and Technology Bureau Leading Talent Program","award":["(No. 2022CXRC9621)"],"award-info":[{"award-number":["(No. 2022CXRC9621)"]}]},{"name":"Graduate Education Reform Project of Gannan Medical University","award":["Nos. GYYJG-2024-01 and GYYJG-2024-03"],"award-info":[{"award-number":["Nos. GYYJG-2024-01 and GYYJG-2024-03"]}]},{"name":"Graduate Education Reform Project of Gannan Medical University","award":["Nos. GYYJG-2024-01 and GYYJG-2024-03"],"award-info":[{"award-number":["Nos. GYYJG-2024-01 and GYYJG-2024-03"]}]},{"name":"Graduate Education Reform Project of Gannan Medical University","award":["Nos. GYYJG-2024-01 and GYYJG-2024-03"],"award-info":[{"award-number":["Nos. GYYJG-2024-01 and GYYJG-2024-03"]}]},{"name":"Graduate Education Reform Project of Gannan Medical University","award":["Nos. GYYJG-2024-01 and GYYJG-2024-03"],"award-info":[{"award-number":["Nos. GYYJG-2024-01 and GYYJG-2024-03"]}]},{"name":"Graduate Education Reform Project of Gannan Medical University","award":["Nos. GYYJG-2024-01 and GYYJG-2024-03"],"award-info":[{"award-number":["Nos. GYYJG-2024-01 and GYYJG-2024-03"]}]},{"name":"Graduate Education Reform Project of Gannan Medical University","award":["Nos. GYYJG-2024-01 and GYYJG-2024-03"],"award-info":[{"award-number":["Nos. GYYJG-2024-01 and GYYJG-2024-03"]}]},{"name":"Graduate Education Reform Project of Gannan Medical University","award":["Nos. GYYJG-2024-01 and GYYJG-2024-03"],"award-info":[{"award-number":["Nos. GYYJG-2024-01 and GYYJG-2024-03"]}]},{"name":"Graduate Education Reform Project of Gannan Medical University","award":["Nos. GYYJG-2024-01 and GYYJG-2024-03"],"award-info":[{"award-number":["Nos. GYYJG-2024-01 and GYYJG-2024-03"]}]},{"name":"Graduate Education Reform Project of Gannan Medical University","award":["Nos. GYYJG-2024-01 and GYYJG-2024-03"],"award-info":[{"award-number":["Nos. GYYJG-2024-01 and GYYJG-2024-03"]}]},{"name":"Graduate Education Reform Project of Gannan Medical University","award":["Nos. GYYJG-2024-01 and GYYJG-2024-03"],"award-info":[{"award-number":["Nos. GYYJG-2024-01 and GYYJG-2024-03"]}]},{"name":"Graduate Education Reform Project of Gannan Medical University","award":["Nos. GYYJG-2024-01 and GYYJG-2024-03"],"award-info":[{"award-number":["Nos. GYYJG-2024-01 and GYYJG-2024-03"]}]},{"name":"Jiangxi Provincial Graduate Innovation Fund Project","award":["YC2023-S940"],"award-info":[{"award-number":["YC2023-S940"]}]},{"name":"Jiangxi Provincial Graduate Innovation Fund Project","award":["YC2023-S940"],"award-info":[{"award-number":["YC2023-S940"]}]},{"name":"Jiangxi Provincial Graduate Innovation Fund Project","award":["YC2023-S940"],"award-info":[{"award-number":["YC2023-S940"]}]},{"name":"Jiangxi Provincial Graduate Innovation Fund Project","award":["YC2023-S940"],"award-info":[{"award-number":["YC2023-S940"]}]},{"name":"Jiangxi Provincial Graduate Innovation Fund Project","award":["YC2023-S940"],"award-info":[{"award-number":["YC2023-S940"]}]},{"name":"Jiangxi Provincial Graduate Innovation Fund Project","award":["YC2023-S940"],"award-info":[{"award-number":["YC2023-S940"]}]},{"name":"Jiangxi Provincial Graduate Innovation Fund Project","award":["YC2023-S940"],"award-info":[{"award-number":["YC2023-S940"]}]},{"name":"Jiangxi Provincial Graduate Innovation Fund Project","award":["YC2023-S940"],"award-info":[{"award-number":["YC2023-S940"]}]},{"name":"Jiangxi Provincial Graduate Innovation Fund Project","award":["YC2023-S940"],"award-info":[{"award-number":["YC2023-S940"]}]},{"name":"Jiangxi Provincial Graduate Innovation Fund Project","award":["YC2023-S940"],"award-info":[{"award-number":["YC2023-S940"]}]},{"name":"Jiangxi Provincial Graduate Innovation Fund Project","award":["YC2023-S940"],"award-info":[{"award-number":["YC2023-S940"]}]},{"name":"Jiangxi Graduate Student Innovation Fund","award":["YC2025-S234"],"award-info":[{"award-number":["YC2025-S234"]}]},{"name":"Jiangxi Graduate Student Innovation Fund","award":["YC2025-S234"],"award-info":[{"award-number":["YC2025-S234"]}]},{"name":"Jiangxi Graduate Student Innovation Fund","award":["YC2025-S234"],"award-info":[{"award-number":["YC2025-S234"]}]},{"name":"Jiangxi Graduate Student Innovation Fund","award":["YC2025-S234"],"award-info":[{"award-number":["YC2025-S234"]}]},{"name":"Jiangxi Graduate Student Innovation Fund","award":["YC2025-S234"],"award-info":[{"award-number":["YC2025-S234"]}]},{"name":"Jiangxi Graduate Student Innovation Fund","award":["YC2025-S234"],"award-info":[{"award-number":["YC2025-S234"]}]},{"name":"Jiangxi Graduate Student Innovation Fund","award":["YC2025-S234"],"award-info":[{"award-number":["YC2025-S234"]}]},{"name":"Jiangxi Graduate Student Innovation Fund","award":["YC2025-S234"],"award-info":[{"award-number":["YC2025-S234"]}]},{"name":"Jiangxi Graduate Student Innovation Fund","award":["YC2025-S234"],"award-info":[{"award-number":["YC2025-S234"]}]},{"name":"Jiangxi Graduate Student Innovation Fund","award":["YC2025-S234"],"award-info":[{"award-number":["YC2025-S234"]}]},{"name":"Jiangxi Graduate Student Innovation Fund","award":["YC2025-S234"],"award-info":[{"award-number":["YC2025-S234"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-026-06709-2","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T09:50:34Z","timestamp":1787133034000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Regulatory networks of non-coding RNAs in renal cell carcinogenesis and therapeutic intervention strategies"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7850-5308","authenticated-orcid":false,"given":"Pengcheng","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geliu","family":"Shuai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuebin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanri","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pufang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4409-5294","authenticated-orcid":false,"given":"Junrong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7472-4488","authenticated-orcid":false,"given":"Xiaofeng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"6709_CR1","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1001\/jama.2024.12848","volume":"332","author":"TL Rose","year":"2024","unstructured":"Rose TL, Kim WY (2024) Renal cell carcinoma. JAMA 332:1001\u20131010. https:\/\/doi.org\/10.1001\/jama.2024.12848","journal-title":"JAMA"},{"key":"6709_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2021.102191","volume":"97","author":"P Barth\u00e9l\u00e9my","year":"2021","unstructured":"Barth\u00e9l\u00e9my P, Rioux-Leclercq N, Thibault C et al (2021) Non-clear cell renal carcinomas: review of new molecular insights and recent clinical data. Cancer Treat Rev 97:102191. https:\/\/doi.org\/10.1016\/j.ctrv.2021.102191","journal-title":"Cancer Treat Rev"},{"key":"6709_CR3","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1148\/rg.2021200202","volume":"41","author":"AM Abou Elkassem","year":"2021","unstructured":"Abou Elkassem AM, Lo SS, Gunn AJ et al (2021) Role of imaging in renal cell carcinoma: a multidisciplinary perspective. Radiographics 41:1387\u20131407. https:\/\/doi.org\/10.1148\/rg.2021200202","journal-title":"Radiographics"},{"key":"6709_CR4","doi-asserted-by":"publisher","first-page":"e498","DOI":"10.1097\/RLU.0000000000004151","volume":"47","author":"P Guglielmo","year":"2022","unstructured":"Guglielmo P, Pesella F, Sartorello A et al (2022) Metastasis from clear cell renal cell carcinoma mimicking well-differentiated pancreatic neuroendocrine tumor at 18F-FDG and 68Ga-DOTATOC PET\/CT. Clin Nucl Med 47:e498\u2013e499. https:\/\/doi.org\/10.1097\/RLU.0000000000004151","journal-title":"Clin Nucl Med"},{"key":"6709_CR5","doi-asserted-by":"publisher","first-page":"e656","DOI":"10.1097\/RLU.0000000000005949","volume":"50","author":"N Jacquet-Francillon","year":"2025","unstructured":"Jacquet-Francillon N, Isal S, Morelec I et al (2025) [68Ga]-DOTATOC PET\/CT and clear cell renal cell carcinoma metastasis: simple false positive or potential staging imaging? Clin Nucl Med 50:e656. https:\/\/doi.org\/10.1097\/RLU.0000000000005949","journal-title":"Clin Nucl Med"},{"key":"6709_CR6","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41585-025-01056-0","volume":"22","author":"PR Nepali","year":"2025","unstructured":"Nepali PR, Eraky A, Okhawere KE et al (2025) Molecular and therapeutic landscape of non-clear cell renal carcinoma. Nat Rev Urol 22:735\u2013755. https:\/\/doi.org\/10.1038\/s41585-025-01056-0","journal-title":"Nat Rev Urol"},{"key":"6709_CR7","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41581-025-00983-w","volume":"21","author":"FH Burgers","year":"2025","unstructured":"Burgers FH, van der Mijn JCK, Seijkens TTP et al (2025) Immunological features of clear-cell renal-cell carcinoma and resistance to immune checkpoint inhibitors. Nat Rev Nephrol 21:687\u2013701. https:\/\/doi.org\/10.1038\/s41581-025-00983-w","journal-title":"Nat Rev Nephrol"},{"key":"6709_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2025.102881","volume":"133","author":"M Santoni","year":"2025","unstructured":"Santoni M, Mollica V, Rizzo A, Massari F (2025) Dynamics of resistance to immunotherapy and TKI in patients with advanced renal cell carcinoma. Cancer Treat Rev 133:102881. https:\/\/doi.org\/10.1016\/j.ctrv.2025.102881","journal-title":"Cancer Treat Rev"},{"key":"6709_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07913-5","volume":"16","author":"H Weng","year":"2025","unstructured":"Weng H, Zhong J, Yang R et al (2025) TRIM59 suppresses mitochondrial-associated apoptosis to facilitate progression in papillary renal cell carcinoma via the ACAT1-cardiolipin pathway. Cell Death Dis 16:606. https:\/\/doi.org\/10.1038\/s41419-025-07913-5","journal-title":"Cell Death Dis"},{"key":"6709_CR10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","volume":"172","author":"F Kopp","year":"2018","unstructured":"Kopp F, Mendell JT (2018) Functional classification and experimental dissection of long noncoding RNAs. Cell 172:393\u2013407. https:\/\/doi.org\/10.1016\/j.cell.2018.01.011","journal-title":"Cell"},{"key":"6709_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrm3838","volume":"15","author":"M Ha","year":"2014","unstructured":"Ha M, Kim VN (2014) Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 15:509\u2013524. https:\/\/doi.org\/10.1038\/nrm3838","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6709_CR12","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41556-019-0311-8","volume":"21","author":"R-W Yao","year":"2019","unstructured":"Yao R-W, Wang Y, Chen L-L (2019) Cellular functions of long noncoding RNAs. Nat Cell Biol 21:542\u2013551. https:\/\/doi.org\/10.1038\/s41556-019-0311-8","journal-title":"Nat Cell Biol"},{"key":"6709_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02488-x","volume":"41","author":"H Khanbabaei","year":"2022","unstructured":"Khanbabaei H, Ebrahimi S, Garc\u00eda-Rodr\u00edguez JL et al (2022) Non-coding RNAs and epithelial mesenchymal transition in cancer: molecular mechanisms and clinical implications. J Exp Clin Cancer Res 41:278. https:\/\/doi.org\/10.1186\/s13046-022-02488-x","journal-title":"J Exp Clin Cancer Res"},{"key":"6709_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115001","volume":"164","author":"Y Liu","year":"2023","unstructured":"Liu Y, Zhang H, Fang Y et al (2023) Non-coding RNAs in renal cell carcinoma: implications for drug resistance. Biomed Pharmacother 164:115001. https:\/\/doi.org\/10.1016\/j.biopha.2023.115001","journal-title":"Biomed Pharmacother"},{"key":"6709_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41585-024-00926-3","volume":"22","author":"T Tesarova","year":"2025","unstructured":"Tesarova T, Fiala O, Hora M, Vaclavikova R (2025) Non-coding transcriptome profiles in clear-cell renal cell carcinoma. Nat Rev Urol 22:151\u2013174. https:\/\/doi.org\/10.1038\/s41585-024-00926-3","journal-title":"Nat Rev Urol"},{"key":"6709_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-04016-1","volume":"26","author":"HA Rizk","year":"2025","unstructured":"Rizk HA, El Said NH, Radwan AF et al (2025) Exploring the role of long non-coding RNAs in renal cell carcinoma: insights into signaling pathways. Cancer Cell Int 26:53. https:\/\/doi.org\/10.1186\/s12935-025-04016-1","journal-title":"Cancer Cell Int"},{"key":"6709_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.omto.2021.08.003","volume":"22","author":"X Chao","year":"2021","unstructured":"Chao X, Wang P, Ma X et al (2021) Comprehensive analysis of lncRNAs as biomarkers for diagnosis, prognosis, and treatment response in clear cell renal cell carcinoma. Mol Ther Oncolytics 22:209\u2013218. https:\/\/doi.org\/10.1016\/j.omto.2021.08.003","journal-title":"Mol Ther Oncolytics"},{"key":"6709_CR18","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.1158\/0008-5472.CAN-16-0473","volume":"76","author":"EM Wallace","year":"2016","unstructured":"Wallace EM, Rizzi JP, Han G et al (2016) A small-molecule antagonist of HIF2\u03b1 is efficacious in preclinical models of renal cell carcinoma. Cancer Res 76:5491\u20135500. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0473","journal-title":"Cancer Res"},{"key":"6709_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature19796","volume":"539","author":"W Chen","year":"2016","unstructured":"Chen W, Hill H, Christie A et al (2016) Targeting renal cell carcinoma with a HIF-2 antagonist. Nature 539:112\u2013117. https:\/\/doi.org\/10.1038\/nature19796","journal-title":"Nature"},{"key":"6709_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12935-025-03711-3","volume":"25","author":"PM Page","year":"2025","unstructured":"Page PM, Dastous SA, Richard PO et al (2025) MicroRNA profiling identifies VHL\/HIF-2\u03b1 dependent miR-2355-5p as a key modulator of clear cell renal cell carcinoma tumor growth. Cancer Cell Int 25:71. https:\/\/doi.org\/10.1186\/s12935-025-03711-3","journal-title":"Cancer Cell Int"},{"key":"6709_CR21","doi-asserted-by":"publisher","first-page":"5639","DOI":"10.1038\/s41388-021-01971-7","volume":"40","author":"M Zhang","year":"2021","unstructured":"Zhang M, Zhang L, Fu L et al (2021) Positive feedback regulation of lncRNA PVT1 and HIF2\u03b1 contributes to clear cell renal cell carcinoma tumorigenesis and metastasis. Oncogene 40:5639\u20135650. https:\/\/doi.org\/10.1038\/s41388-021-01971-7","journal-title":"Oncogene"},{"key":"6709_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12943-024-01940-0","volume":"23","author":"B Huang","year":"2024","unstructured":"Huang B, Ren J, Ma Q et al (2024) A novel peptide PDHK1-241aa encoded by circPDHK1 promotes ccRCC progression via interacting with PPP1CA to inhibit AKT dephosphorylation and activate the AKT-mTOR signaling pathway. Mol Cancer 23:34. https:\/\/doi.org\/10.1186\/s12943-024-01940-0","journal-title":"Mol Cancer"},{"key":"6709_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2021.188559","volume":"1876","author":"S Chakraborty","year":"2021","unstructured":"Chakraborty S, Balan M, Sabarwal A et al (2021) Metabolic reprogramming in renal cancer: events of a metabolic disease. Biochim Biophys Acta Rev Cancer 1876:188559. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188559","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"6709_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/path.5394","volume":"251","author":"C Nakada","year":"2020","unstructured":"Nakada C, Hijiya N, Tsukamoto Y et al (2020) A transgenic mouse expressing miR-210 in proximal tubule cells shows mitochondrial alteration: possible association of miR-210 with a shift in energy metabolism. J Pathol 251:12\u201325. https:\/\/doi.org\/10.1002\/path.5394","journal-title":"J Pathol"},{"key":"6709_CR25","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/bjc.2013.56","volume":"108","author":"RI McCormick","year":"2013","unstructured":"McCormick RI, Blick C, Ragoussis J et al (2013) MiR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis. Br J Cancer 108:1133\u20131142. https:\/\/doi.org\/10.1038\/bjc.2013.56","journal-title":"Br J Cancer"},{"key":"6709_CR26","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1158\/0008-5472.CAN-20-0832","volume":"81","author":"P Kulkarni","year":"2021","unstructured":"Kulkarni P, Dasgupta P, Hashimoto Y et al (2021) A lncRNA TCL6-miR-155 interaction regulates the Src-Akt-EMT network to mediate kidney cancer progression and metastasis. Cancer Res 81:1500\u20131512. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-0832","journal-title":"Cancer Res"},{"key":"6709_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41420-021-00525-w","volume":"7","author":"W Gu","year":"2021","unstructured":"Gu W, Gong L, Wu X, Yao X (2021) Hypoxic TAM-derived exosomal miR-155-5p promotes RCC progression through HuR-dependent IGF1R\/AKT\/PI3K pathway. Cell Death Discov 7:147. https:\/\/doi.org\/10.1038\/s41420-021-00525-w","journal-title":"Cell Death Discov"},{"key":"6709_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03958-4","volume":"12","author":"J Wang","year":"2021","unstructured":"Wang J, Zou Y, Du B et al (2021) SNP-mediated lncRNA-ENTPD3-AS1 upregulation suppresses renal cell carcinoma via miR-155\/HIF-1\u03b1 signaling. Cell Death Dis 12:672. https:\/\/doi.org\/10.1038\/s41419-021-03958-4","journal-title":"Cell Death Dis"},{"key":"6709_CR29","doi-asserted-by":"publisher","first-page":"5900","DOI":"10.1021\/acs.jmedchem.7b01891","volume":"61","author":"Y Naro","year":"2018","unstructured":"Naro Y, Ankenbruck N, Thomas M et al (2018) Small molecule inhibition of microRNA miR-21 rescues chemosensitivity of renal-cell carcinoma to topotecan. J Med Chem 61:5900\u20135909. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b01891","journal-title":"J Med Chem"},{"key":"6709_CR30","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/febs.14011","volume":"284","author":"N Teteloshvili","year":"2017","unstructured":"Teteloshvili N, Smigielska-Czepiel K, Yuan Y et al (2017) Argonaute 2 immunoprecipitation revealed large tumor suppressor kinase 1 as a novel proapoptotic target of miR-21 in T cells. FEBS J 284:555\u2013567. https:\/\/doi.org\/10.1111\/febs.14011","journal-title":"FEBS J"},{"key":"6709_CR31","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1007\/s12672-025-03263-y","volume":"16","author":"M-Y Xu","year":"2025","unstructured":"Xu M-Y, Wang X, Yue S et al (2025) hsa-miR-21-5p can serve as a standard biomarker in clear cell renal cell carcinoma by promoting tumor progression and influencing immune evasion. Discov Oncol 16:1738. https:\/\/doi.org\/10.1007\/s12672-025-03263-y","journal-title":"Discov Oncol"},{"key":"6709_CR32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/cells12010173","volume":"12","author":"M Xie","year":"2022","unstructured":"Xie M, Cheng B, Yu S et al (2022) Cuproptosis-related miR-21-5p\/FDX1 axis in clear cell renal cell carcinoma and its potential impact on tumor microenvironment. Cells 12:173. https:\/\/doi.org\/10.3390\/cells12010173","journal-title":"Cells"},{"key":"6709_CR33","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.ymthe.2019.03.004","volume":"27","author":"T Takai","year":"2019","unstructured":"Takai T, Tsujino T, Yoshikawa Y et al (2019) Synthetic miR-143 exhibited an anti-cancer effect via the downregulation of K-RAS networks of renal cell cancer cells in vitro and in vivo. Mol Ther 27:1017\u20131027. https:\/\/doi.org\/10.1016\/j.ymthe.2019.03.004","journal-title":"Mol Ther"},{"key":"6709_CR34","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1111\/cas.13559","volume":"109","author":"Y Akao","year":"2018","unstructured":"Akao Y, Kumazaki M, Shinohara H et al (2018) Impairment of K-Ras signaling networks and increased efficacy of epidermal growth factor receptor inhibitors by a novel synthetic miR-143. Cancer Sci 109:1455\u20131467. https:\/\/doi.org\/10.1111\/cas.13559","journal-title":"Cancer Sci"},{"key":"6709_CR35","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.ebiom.2019.05.041","volume":"44","author":"Y Li","year":"2019","unstructured":"Li Y, Guan B, Liu J et al (2019) MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma. EBioMedicine 44:439\u2013451. https:\/\/doi.org\/10.1016\/j.ebiom.2019.05.041","journal-title":"EBioMedicine"},{"key":"6709_CR36","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12935-019-0944-5","volume":"19","author":"S Li","year":"2019","unstructured":"Li S, Feng Z, Zhang X et al (2019) Up-regulation of microRNA-200c-3p inhibits invasion and migration of renal cell carcinoma cells via the SOX2-dependent Wnt\/\u03b2-catenin signaling pathway. Cancer Cell Int 19:231. https:\/\/doi.org\/10.1186\/s12935-019-0944-5","journal-title":"Cancer Cell Int"},{"key":"6709_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110215","volume":"127","author":"J Wang","year":"2020","unstructured":"Wang J, Wang C, Li Q et al (2020) MiR-429-CRKL axis regulates clear cell renal cell carcinoma malignant progression through SOS1\/MEK\/ERK\/MMP2\/MMP9 pathway. Biomed Pharmacother 127:110215. https:\/\/doi.org\/10.1016\/j.biopha.2020.110215","journal-title":"Biomed Pharmacother"},{"key":"6709_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.252","volume":"8","author":"Z Chen","year":"2017","unstructured":"Chen Z, Zhang J, Zhang Z et al (2017) The putative tumor suppressor microRNA-30a-5p modulates clear cell renal cell carcinoma aggressiveness through repression of ZEB2. Cell Death Dis 8:e2859. https:\/\/doi.org\/10.1038\/cddis.2017.252","journal-title":"Cell Death Dis"},{"key":"6709_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12967-020-02242-x","volume":"18","author":"J Chen","year":"2020","unstructured":"Chen J, Zhong Y, Li L (2020) MiR-124 and miR-203 synergistically inactivate EMT pathway via coregulation of ZEB2 in clear cell renal cell carcinoma (ccRCC). J Transl Med 18:69. https:\/\/doi.org\/10.1186\/s12967-020-02242-x","journal-title":"J Transl Med"},{"key":"6709_CR40","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.7150\/ijbs.60805","volume":"17","author":"J Cui","year":"2021","unstructured":"Cui J, Yuan Y, Shanmugam MK et al (2021) MicroRNA-196a promotes renal cancer cell migration and invasion by targeting BRAM1 to regulate SMAD and MAPK signaling pathways. Int J Biol Sci 17:4254\u20134270. https:\/\/doi.org\/10.7150\/ijbs.60805","journal-title":"Int J Biol Sci"},{"key":"6709_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12943-018-0906-x","volume":"17","author":"W Zhai","year":"2018","unstructured":"Zhai W, Li S, Zhang J et al (2018) Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4\/SMAD7 signals. Mol Cancer 17:157. https:\/\/doi.org\/10.1186\/s12943-018-0906-x","journal-title":"Mol Cancer"},{"key":"6709_CR42","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3233\/CBM-190242","volume":"27","author":"V Petrozza","year":"2020","unstructured":"Petrozza V, Costantini M, Tito C et al (2020) Emerging role of secreted miR-210-3p as potential biomarker for clear cell renal cell carcinoma metastasis. Cancer Biomark 27:181\u2013188. https:\/\/doi.org\/10.3233\/CBM-190242","journal-title":"Cancer Biomark"},{"key":"6709_CR43","doi-asserted-by":"publisher","unstructured":"Jy B, BJ, Jb M, et al (2021) HOTAIR and androgen receptor synergistically increase GLI2 transcription to promote tumor angiogenesis and cancer stemness in renal cell carcinoma. Cancer Lett 498. https:\/\/doi.org\/10.1016\/j.canlet.2020.10.031","DOI":"10.1016\/j.canlet.2020.10.031"},{"key":"6709_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-023-03438-1","volume":"24","author":"O Anbiyaee","year":"2023","unstructured":"Anbiyaee O, Moalemnia A, Ghaedrahmati F et al (2023) The functions of long non-coding RNA (lncRNA)-MALAT-1 in the pathogenesis of renal cell carcinoma. BMC Nephrol 24:380. https:\/\/doi.org\/10.1186\/s12882-023-03438-1","journal-title":"BMC Nephrol"},{"key":"6709_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222011193","volume":"22","author":"EA Braga","year":"2021","unstructured":"Braga EA, Fridman MV, Filippova EA et al (2021) LncRNAs in the regulation of genes and signaling pathways through miRNA-mediated and other mechanisms in clear cell renal cell carcinoma. Int J Mol Sci 22:11193. https:\/\/doi.org\/10.3390\/ijms222011193","journal-title":"Int J Mol Sci"},{"key":"6709_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03955-7","volume":"12","author":"R Guo","year":"2021","unstructured":"Guo R, Zou B, Liang Y et al (2021) LncRNA RCAT1 promotes tumor progression and metastasis via miR-214-5p\/E2F2 axis in renal cell carcinoma. Cell Death Dis 12:689. https:\/\/doi.org\/10.1038\/s41419-021-03955-7","journal-title":"Cell Death Dis"},{"key":"6709_CR47","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s41467-017-00902-z","volume":"8","author":"Z-D Xiao","year":"2017","unstructured":"Xiao Z-D, Han L, Lee H et al (2017) Energy stress-induced lncRNA FILNC1 represses c-Myc-mediated energy metabolism and inhibits renal tumor development. Nat Commun 8:783. https:\/\/doi.org\/10.1038\/s41467-017-00902-z","journal-title":"Nat Commun"},{"key":"6709_CR48","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.omtn.2019.04.005","volume":"16","author":"H Zhou","year":"2019","unstructured":"Zhou H, Tang K, Liu H et al (2019) Regulatory network of two tumor-suppressive noncoding RNAs interferes with the growth and metastasis of renal cell carcinoma. Mol Ther Nucleic Acids 16:554\u2013565. https:\/\/doi.org\/10.1016\/j.omtn.2019.04.005","journal-title":"Mol Ther Nucleic Acids"},{"key":"6709_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24442","volume":"36","author":"J Bohosova","year":"2022","unstructured":"Bohosova J, Kasik M, Kubickova A et al (2022) LncRNA PVT1 is increased in renal cell carcinoma and affects viability and migration in vitro. J Clin Lab Anal 36:e24442. https:\/\/doi.org\/10.1002\/jcla.24442","journal-title":"J Clin Lab Anal"},{"key":"6709_CR50","doi-asserted-by":"publisher","first-page":"10406","DOI":"10.1002\/jcb.27389","volume":"119","author":"C Ding","year":"2018","unstructured":"Ding C, Han F, Xiang H et al (2018) LncRNA CRNDE is a biomarker for clinical progression and poor prognosis in clear cell renal cell carcinoma. J Cell Biochem 119:10406\u201310414. https:\/\/doi.org\/10.1002\/jcb.27389","journal-title":"J Cell Biochem"},{"key":"6709_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02467-2","volume":"41","author":"W Mao","year":"2022","unstructured":"Mao W, Wang K, Zhang W et al (2022) Transfection with plasmid-encoding lncRNA-SLERCC nanoparticle-mediated delivery suppressed tumor progression in renal cell carcinoma. J Exp Clin Cancer Res 41:252. https:\/\/doi.org\/10.1186\/s13046-022-02467-2","journal-title":"J Exp Clin Cancer Res"},{"key":"6709_CR52","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1038\/s41388-023-02666-x","volume":"42","author":"J Lu","year":"2023","unstructured":"Lu J, Fu L, Cao Y et al (2023) LZTFL1 inhibits kidney tumor cell growth by destabilizing AKT through ZNRF1-mediated ubiquitin proteosome pathway. Oncogene 42:1543\u20131557. https:\/\/doi.org\/10.1038\/s41388-023-02666-x","journal-title":"Oncogene"},{"key":"6709_CR53","doi-asserted-by":"publisher","unstructured":"LD, BW, MW, et al (2023) LINC00926 promotes progression of renal cell carcinoma via regulating miR-30a-5p\/SOX4 axis and activating IFN\u03b3-JAK2-STAT1 pathway. Cancer Lett 578. https:\/\/doi.org\/10.1016\/j.canlet.2023.216463","DOI":"10.1016\/j.canlet.2023.216463"},{"key":"6709_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1735169","volume":"17","author":"J Tong","year":"2026","unstructured":"Tong J, Liu Y, Tang A et al (2026) Unraveling the role of LINC02657 in clear cell renal cell carcinoma: insights into tumor aggression, immune modulation, and treatment response. Front Immunol 17:1735169. https:\/\/doi.org\/10.3389\/fimmu.2026.1735169","journal-title":"Front Immunol"},{"key":"6709_CR55","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"Kristensen LS, Andersen MS, Stagsted LVW et al (2019) The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet 20:675\u2013691. https:\/\/doi.org\/10.1038\/s41576-019-0158-7","journal-title":"Nat Rev Genet"},{"key":"6709_CR56","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12943-020-01266-7","volume":"19","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhang Y, Wang P et al (2020) Circular RNAs in renal cell carcinoma: implications for tumorigenesis, diagnosis, and therapy. Mol Cancer 19:149. https:\/\/doi.org\/10.1186\/s12943-020-01266-7","journal-title":"Mol Cancer"},{"key":"6709_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-024-02122-8","volume":"24","author":"Y Wang","year":"2025","unstructured":"Wang Y, Yang T, Li Q et al (2025) CircASAP1 induces renal clear cell carcinoma ferroptosis by binding to HNRNPC and thereby regulating GPX4. Mol Cancer 24:1. https:\/\/doi.org\/10.1186\/s12943-024-02122-8","journal-title":"Mol Cancer"},{"key":"6709_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05488-z","volume":"13","author":"B Zhao","year":"2022","unstructured":"Zhao B, Huang C, Pan J et al (2022) CircPLIN2 promotes clear cell renal cell carcinoma progression by binding IGF2BP proteins and miR-199a-3p. Cell Death Dis 13:1030. https:\/\/doi.org\/10.1038\/s41419-022-05488-z","journal-title":"Cell Death Dis"},{"key":"6709_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202501211","volume":"12","author":"H Zhang","year":"2025","unstructured":"Zhang H, Tao T, Ji J et al (2025) CircPVT1 promotes lung metastasis and tumor progression in renal cell carcinoma by encoding the cP104aa peptide and targeting EIF4A3. Adv Sci (Weinh) 12:e01211. https:\/\/doi.org\/10.1002\/advs.202501211","journal-title":"Adv Sci (Weinh)"},{"key":"6709_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.994","volume":"12","author":"X Pan","year":"2022","unstructured":"Pan X, Huang B, Ma Q et al (2022) Circular RNA circ-TNPO3 inhibits clear cell renal cell carcinoma metastasis by binding to IGF2BP2 and destabilizing SERPINH1 mRNA. Clin Transl Med 12:e994. https:\/\/doi.org\/10.1002\/ctm2.994","journal-title":"Clin Transl Med"},{"key":"6709_CR61","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41420-022-00865-1","volume":"8","author":"Y Ou","year":"2022","unstructured":"Ou Y, Dai X, Chen X et al (2022) Circ-AFAP1 promote clear cell renal cell carcinoma growth and angiogenesis by the Circ-AFAP1\/miR-374b-3p\/VEGFA signaling axis. Cell Death Discov 8:68. https:\/\/doi.org\/10.1038\/s41420-022-00865-1","journal-title":"Cell Death Discov"},{"key":"6709_CR62","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12943-021-01449-w","volume":"20","author":"C-P Gui","year":"2021","unstructured":"Gui C-P, Liao B, Luo C-G et al (2021) CircCHST15 is a novel prognostic biomarker that promotes clear cell renal cell carcinoma cell proliferation and metastasis through the miR-125a-5p\/EIF4EBP1 axis. Mol Cancer 20:169. https:\/\/doi.org\/10.1186\/s12943-021-01449-w","journal-title":"Mol Cancer"},{"key":"6709_CR63","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.7150\/ijbs.69351","volume":"18","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang Y, Su X et al (2022) Circular RNA circDVL1 inhibits clear cell renal cell carcinoma progression through the miR-412-3p\/PCDH7 axis. Int J Biol Sci 18:1491\u20131507. https:\/\/doi.org\/10.7150\/ijbs.69351","journal-title":"Int J Biol Sci"},{"key":"6709_CR64","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/s41419-021-04366-4","volume":"12","author":"L-J Gong","year":"2021","unstructured":"Gong L-J, Wang X-Y, Yao X et al (2021) CircESRP1 inhibits clear cell renal cell carcinoma progression through the CTCF-mediated positive feedback loop. Cell Death Dis 12:1081. https:\/\/doi.org\/10.1038\/s41419-021-04366-4","journal-title":"Cell Death Dis"},{"key":"6709_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01694-7","volume":"21","author":"Y Liang","year":"2022","unstructured":"Liang Y, Cen J, Huang Y et al (2022) CircNTNG1 inhibits renal cell carcinoma progression via HOXA5-mediated epigenetic silencing of Slug. Mol Cancer 21:224. https:\/\/doi.org\/10.1186\/s12943-022-01694-7","journal-title":"Mol Cancer"},{"key":"6709_CR66","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41419-022-04623-0","volume":"13","author":"X Wu","year":"2022","unstructured":"Wu X, Zhou J, Zhao L et al (2022) CircCYP24A1 hampered malignant phenotype of renal cancer carcinoma through modulating CMTM-4 expression via sponging miR-421. Cell Death Dis 13:190. https:\/\/doi.org\/10.1038\/s41419-022-04623-0","journal-title":"Cell Death Dis"},{"key":"6709_CR67","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrg.2016.20","volume":"17","author":"DW Thomson","year":"2016","unstructured":"Thomson DW, Dinger ME (2016) Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet 17:272\u2013283. https:\/\/doi.org\/10.1038\/nrg.2016.20","journal-title":"Nat Rev Genet"},{"key":"6709_CR68","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","volume":"495","author":"TB Hansen","year":"2013","unstructured":"Hansen TB, Jensen TI, Clausen BH et al (2013) Natural RNA circles function as efficient microRNA sponges. Nature 495:384\u2013388. https:\/\/doi.org\/10.1038\/nature11993","journal-title":"Nature"},{"key":"6709_CR69","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10456-017-9545-x","volume":"20","author":"JR van Beijnum","year":"2017","unstructured":"van Beijnum JR, Giovannetti E, Poel D et al (2017) MiRNAs: micro-managers of anticancer combination therapies. Angiogenesis 20:269\u2013285. https:\/\/doi.org\/10.1007\/s10456-017-9545-x","journal-title":"Angiogenesis"},{"key":"6709_CR70","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.jgg.2021.05.016","volume":"48","author":"M Shulman","year":"2021","unstructured":"Shulman M, Shi R, Zhang Q (2021) Von Hippel-Lindau tumor suppressor pathways & corresponding therapeutics in kidney cancer. J Genet Genomics 48:552\u2013559. https:\/\/doi.org\/10.1016\/j.jgg.2021.05.016","journal-title":"J Genet Genomics"},{"key":"6709_CR71","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","volume":"122","author":"DS Hong","year":"2020","unstructured":"Hong DS, Kang Y-K, Borad M et al (2020) Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. Br J Cancer 122:1630\u20131637. https:\/\/doi.org\/10.1038\/s41416-020-0802-1","journal-title":"Br J Cancer"},{"key":"6709_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1059-5","volume":"38","author":"L Zhang","year":"2019","unstructured":"Zhang L, Liao Y, Tang L (2019) MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer. J Exp Clin Cancer Res 38:53. https:\/\/doi.org\/10.1186\/s13046-019-1059-5","journal-title":"J Exp Clin Cancer Res"},{"key":"6709_CR73","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.atherosclerosis.2022.12.003","volume":"374","author":"G Saenz-Pipaon","year":"2023","unstructured":"Saenz-Pipaon G, Dichek DA (2023) Targeting and delivery of microRNA-targeting antisense oligonucleotides in cardiovascular diseases. Atherosclerosis 374:44\u201354. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.12.003","journal-title":"Atherosclerosis"},{"key":"6709_CR74","doi-asserted-by":"publisher","unstructured":"Patutina OA, Gaponova (Miroshnichenko) SK, Sen\u2019kova AV, et al (2020) Mesyl phosphoramidate backbone modified antisense oligonucleotides targeting miR-21 with enhanced in vivo therapeutic potency. Proc Natl Acad Sci USA 117:32370\u201332379. https:\/\/doi.org\/10.1073\/pnas.2016158117","DOI":"10.1073\/pnas.2016158117"},{"key":"6709_CR75","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41592-024-02190-0","volume":"21","author":"JJ Montero","year":"2024","unstructured":"Montero JJ, Trozzo R, Sugden M et al (2024) Genome-scale pan-cancer interrogation of lncRNA dependencies using CasRx. Nat Methods 21:584\u2013596. https:\/\/doi.org\/10.1038\/s41592-024-02190-0","journal-title":"Nat Methods"},{"key":"6709_CR76","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41419-025-07456-9","volume":"16","author":"Y Pan","year":"2025","unstructured":"Pan Y, Liu S, Shu G et al (2025) STX17-DT facilitates axitinib resistance in renal cell carcinoma by inhibiting mitochondrial ROS accumulation and ferroptosis. Cell Death Dis 16:125. https:\/\/doi.org\/10.1038\/s41419-025-07456-9","journal-title":"Cell Death Dis"},{"key":"6709_CR77","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/nar\/gkab1208","volume":"50","author":"X Mou","year":"2021","unstructured":"Mou X, Liew SW, Kwok CK (2021) Identification and targeting of G-quadruplex structures in MALAT1 long non-coding RNA. Nucleic Acids Res 50:397\u2013410. https:\/\/doi.org\/10.1093\/nar\/gkab1208","journal-title":"Nucleic Acids Res"},{"key":"6709_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01912-w","volume":"23","author":"Z Zheng","year":"2024","unstructured":"Zheng Z, Zeng X, Zhu Y et al (2024) CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeting the miR-182-5p\/CYP1B1 axis. Mol Cancer 23:4. https:\/\/doi.org\/10.1186\/s12943-023-01912-w","journal-title":"Mol Cancer"},{"key":"6709_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01607-8","volume":"21","author":"Z Xu","year":"2022","unstructured":"Xu Z, Chen S, Liu R et al (2022) Circular RNA circPOLR2A promotes clear cell renal cell carcinoma progression by facilitating the UBE3C-induced ubiquitination of PEBP1 and, thereby, activating the ERK signaling pathway. Mol Cancer 21:146. https:\/\/doi.org\/10.1186\/s12943-022-01607-8","journal-title":"Mol Cancer"},{"key":"6709_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02790-w","volume":"22","author":"S Qin","year":"2022","unstructured":"Qin S, Wang Y, Wang P, Lv Q (2022) Molecular mechanism of circRNAs in drug resistance in renal cell carcinoma. Cancer Cell Int 22:369. https:\/\/doi.org\/10.1186\/s12935-022-02790-w","journal-title":"Cancer Cell Int"},{"key":"6709_CR81","doi-asserted-by":"publisher","DOI":"10.1148\/rg.220209","volume":"43","author":"AS Shetty","year":"2023","unstructured":"Shetty AS, Fraum TJ, Ballard DH et al (2023) Renal mass imaging with MRI clear cell likelihood score: a user\u2019s guide. Radiographics 43:e220209. https:\/\/doi.org\/10.1148\/rg.220209","journal-title":"Radiographics"},{"key":"6709_CR82","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1038\/s41551-023-01081-7","volume":"7","author":"RE Reggiardo","year":"2023","unstructured":"Reggiardo RE, Maroli SV, Peddu V et al (2023) Profiling of repetitive RNA sequences in the blood plasma of patients with cancer. Nat Biomed Eng 7:1627\u20131635. https:\/\/doi.org\/10.1038\/s41551-023-01081-7","journal-title":"Nat Biomed Eng"},{"key":"6709_CR83","doi-asserted-by":"publisher","first-page":"23382","DOI":"10.3390\/ijms161023382","volume":"16","author":"M Fedorko","year":"2015","unstructured":"Fedorko M, Stanik M, Iliev R et al (2015) Combination of MiR-378 and MiR-210 serum levels enables sensitive detection of renal cell carcinoma. Int J Mol Sci 16:23382\u201323389. https:\/\/doi.org\/10.3390\/ijms161023382","journal-title":"Int J Mol Sci"},{"key":"6709_CR84","doi-asserted-by":"publisher","first-page":"888","DOI":"10.21873\/cgp.20545","volume":"22","author":"M Kasik","year":"2025","unstructured":"Kasik M, Iliev R, Vychytilova P et al (2025) Circulating serum piRNAs as diagnostic and prognostic tools for clear cell renal cell carcinoma. Cancer Genomics Proteomics 22:888\u2013899. https:\/\/doi.org\/10.21873\/cgp.20545","journal-title":"Cancer Genomics Proteomics"},{"key":"6709_CR85","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1002\/2211-5463.12930","volume":"10","author":"J Xie","year":"2020","unstructured":"Xie J, Zhong Y, Chen R et al (2020) Serum long non-coding RNA LINC00887 as a potential biomarker for diagnosis of renal cell carcinoma. FEBS Open Bio 10:1802\u20131809. https:\/\/doi.org\/10.1002\/2211-5463.12930","journal-title":"FEBS Open Bio"},{"key":"6709_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17091442","volume":"17","author":"GS Netti","year":"2025","unstructured":"Netti GS, De Luca F, Camporeale V et al (2025) Liquid biopsy as a new tool for diagnosis and monitoring in renal cell carcinoma. Cancers (Basel) 17:1442. https:\/\/doi.org\/10.3390\/cancers17091442","journal-title":"Cancers (Basel)"},{"key":"6709_CR87","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1515\/cclm-2016-0471","volume":"55","author":"J Khan","year":"2017","unstructured":"Khan J, Lieberman JA, Lockwood CM (2017) Variability in, variability out: best practice recommendations to standardize pre-analytical variables in the detection of circulating and tissue microRNAs. Clin Chem Lab Med (CCLM) 55:608\u2013621. https:\/\/doi.org\/10.1515\/cclm-2016-0471","journal-title":"Clin Chem Lab Med (CCLM)"},{"key":"6709_CR88","doi-asserted-by":"publisher","DOI":"10.11613\/BM.2024.020501","author":"M Zendjabil","year":"2024","unstructured":"Zendjabil M (2024) Preanalytical, analytical and postanalytical considerations in circulating microRNAs measurement. Biochem Med (Zagreb). https:\/\/doi.org\/10.11613\/BM.2024.020501","journal-title":"Biochem Med (Zagreb)"},{"key":"6709_CR89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064795","volume":"8","author":"HH Cheng","year":"2013","unstructured":"Cheng HH, Yi HS, Kim Y et al (2013) Plasma processing conditions substantially influence circulating microRNA biomarker levels. PLoS ONE 8:e64795. https:\/\/doi.org\/10.1371\/journal.pone.0064795","journal-title":"PLoS ONE"},{"key":"6709_CR90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167969","volume":"12","author":"C Glinge","year":"2017","unstructured":"Glinge C, Clauss S, Boddum K et al (2017) Stability of circulating blood-based microRNAs \u2013 pre-analytic methodological considerations. PLoS ONE 12:e0167969. https:\/\/doi.org\/10.1371\/journal.pone.0167969","journal-title":"PLoS ONE"},{"key":"6709_CR91","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.ygeno.2021.01.016","volume":"113","author":"C-P Gui","year":"2021","unstructured":"Gui C-P, Cao J-Z, Tan L et al (2021) A panel of eight autophagy-related long non-coding RNAs is a good predictive parameter for clear cell renal cell carcinoma. Genomics 113:740\u2013754. https:\/\/doi.org\/10.1016\/j.ygeno.2021.01.016","journal-title":"Genomics"},{"key":"6709_CR92","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.7150\/jca.94685","volume":"15","author":"G Chen","year":"2024","unstructured":"Chen G, Zhang T, Li F et al (2024) A model to predict prognosis of renal cell clear cell carcinoma based on 3 angiogenesis-related long non-coding RNAs. J Cancer 15:3481\u20133494. https:\/\/doi.org\/10.7150\/jca.94685","journal-title":"J Cancer"},{"key":"6709_CR93","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1002\/cam4.3820","volume":"10","author":"J Yu","year":"2021","unstructured":"Yu J, Mao W, Xu B, Chen M (2021) Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients. Cancer Med 10:2359\u20132369. https:\/\/doi.org\/10.1002\/cam4.3820","journal-title":"Cancer Med"},{"key":"6709_CR94","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1186\/s12935-021-02284-1","volume":"21","author":"X-L Xing","year":"2021","unstructured":"Xing X-L, Yao Z-Y, Ou J et al (2021) Development and validation of ferroptosis-related lncRNAs prognosis signatures in kidney renal clear cell carcinoma. Cancer Cell Int 21:591. https:\/\/doi.org\/10.1186\/s12935-021-02284-1","journal-title":"Cancer Cell Int"},{"key":"6709_CR95","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.biopha.2018.06.081","volume":"105","author":"F Peng","year":"2018","unstructured":"Peng F, Shi X, Meng Y et al (2018) Long non-coding RNA HOTTIP is upregulated in renal cell carcinoma and regulates cell growth and apoptosis by epigenetically silencing of LATS2. Biomed Pharmacother 105:1133\u20131140. https:\/\/doi.org\/10.1016\/j.biopha.2018.06.081","journal-title":"Biomed Pharmacother"},{"key":"6709_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.777349","volume":"9","author":"J Chen","year":"2021","unstructured":"Chen J, Liao X, Cheng J et al (2021) Targeted methylation of the LncRNA NEAT1 suppresses malignancy of renal cell carcinoma. Front Cell Dev Biol 9:777349. https:\/\/doi.org\/10.3389\/fcell.2021.777349","journal-title":"Front Cell Dev Biol"},{"key":"6709_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-83263-0","volume":"14","author":"X Zhang","year":"2024","unstructured":"Zhang X, Hu J, Zheng H et al (2024) Development and validation of a prognostic model based on m6A-related lncRNAs to predict prognosis for papillary renal cell cancer patients. Sci Rep 14:31460. https:\/\/doi.org\/10.1038\/s41598-024-83263-0","journal-title":"Sci Rep"},{"key":"6709_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021464","volume":"24","author":"Y Pang","year":"2023","unstructured":"Pang Y, Wang Y, Zhou X et al (2023) Cuproptosis-related LncRNA-based prediction of the prognosis and immunotherapy response in papillary renal cell carcinoma. Int J Mol Sci 24:1464. https:\/\/doi.org\/10.3390\/ijms24021464","journal-title":"Int J Mol Sci"},{"key":"6709_CR99","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.3892\/or.2017.5402","volume":"37","author":"Z Liu","year":"2017","unstructured":"Liu Z, Lu Y, Xiao Y, Lu Y (2017) Upregulation of miR-21 expression is a valuable predicator of advanced clinicopathological features and poor prognosis in patients with renal cell carcinoma through the p53\/p21-cyclin E2-Bax\/caspase-3 signaling pathway. Oncol Rep 37:1437\u20131444. https:\/\/doi.org\/10.3892\/or.2017.5402","journal-title":"Oncol Rep"},{"key":"6709_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/ncrna12020008","volume":"12","author":"M Cecati","year":"2026","unstructured":"Cecati M, Pozzi V, Schiavoni V et al (2026) Short and long non-coding RNAs in renal cell carcinoma. Non-coding RNA 12:8. https:\/\/doi.org\/10.3390\/ncrna12020008","journal-title":"Non-coding RNA"},{"key":"6709_CR101","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41416-025-03008-2","volume":"133","author":"\u00c1 Pinto-Mar\u00edn","year":"2025","unstructured":"Pinto-Mar\u00edn \u00c1, Trilla-Fuertes L, Miranda Poma J et al (2025) A prognostic microRNA-based signature for localized clear cell renal cell carcinoma: the Bio-miR study. Br J Cancer 133:155\u2013167. https:\/\/doi.org\/10.1038\/s41416-025-03008-2","journal-title":"Br J Cancer"},{"key":"6709_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.144242","volume":"313","author":"Z Chen","year":"2025","unstructured":"Chen Z, Jia X, Meng K et al (2025) A novel peptide TCL6148 induces ferroptosis via the GOT1\/GPX4 pathway to enhance sunitinib sensitivity in renal cell carcinoma. Int J Biol Macromol 313:144242. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.144242","journal-title":"Int J Biol Macromol"},{"key":"6709_CR103","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41392-022-00975-3","volume":"7","author":"B Chen","year":"2022","unstructured":"Chen B, Dragomir MP, Yang C et al (2022) Targeting non-coding RNAs to overcome cancer therapy resistance. Signal Transduct Target Ther 7:121. https:\/\/doi.org\/10.1038\/s41392-022-00975-3","journal-title":"Signal Transduct Target Ther"},{"key":"6709_CR104","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1268745","volume":"14","author":"M Wang","year":"2023","unstructured":"Wang M, Yu F, Li P (2023) Noncoding RNAs as an emerging resistance mechanism to immunotherapies in cancer: basic evidence and therapeutic implications. Front Immunol 14:1268745. https:\/\/doi.org\/10.3389\/fimmu.2023.1268745","journal-title":"Front Immunol"},{"key":"6709_CR105","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41581-025-01011-7","volume":"22","author":"J Prins","year":"2026","unstructured":"Prins J, Biscans A, Jan van Zonneveld A et al (2026) RNA-based therapeutic opportunities for the treatment of kidney diseases. Nat Rev Nephrol 22:12\u201329. https:\/\/doi.org\/10.1038\/s41581-025-01011-7","journal-title":"Nat Rev Nephrol"},{"key":"6709_CR106","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1007\/s13346-024-01583-0","volume":"14","author":"J Rodr\u00edguez-Castej\u00f3n","year":"2024","unstructured":"Rodr\u00edguez-Castej\u00f3n J, Beraza-Millor M, Solin\u00eds M\u00c1 et al (2024) Targeting strategies with lipid vectors for nucleic acid supplementation therapy in Fabry disease: a systematic review. Drug Deliv Transl Res 14:2615\u20132628. https:\/\/doi.org\/10.1007\/s13346-024-01583-0","journal-title":"Drug Deliv Transl Res"},{"key":"6709_CR107","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-01987-5","volume":"16","author":"S Ao","year":"2025","unstructured":"Ao S, Liang L, Peng L et al (2025) Identification and validation of an m5C-related lncRNA signature for predicting prognosis and immune response in clear cell renal cell carcinoma. Discov Oncol 16:227. https:\/\/doi.org\/10.1007\/s12672-025-01987-5","journal-title":"Discov Oncol"},{"key":"6709_CR108","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000043052","volume":"104","author":"B Lu","year":"2025","unstructured":"Lu B, Wu J, Niu Y et al (2025) Construction of a risk model based on m5C-associated lncRNAs to predict the prognosis in renal cell carcinoma. Medicine (Baltimore) 104:e43052. https:\/\/doi.org\/10.1097\/MD.0000000000043052","journal-title":"Medicine (Baltimore)"},{"key":"6709_CR109","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13045-024-01591-0","volume":"17","author":"Y Zhang","year":"2024","unstructured":"Zhang Y (2024) LncRNA-encoded peptides in cancer. J Hematol Oncol 17:66. https:\/\/doi.org\/10.1186\/s13045-024-01591-0","journal-title":"J Hematol Oncol"},{"key":"6709_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111421","volume":"124","author":"Z Chen","year":"2024","unstructured":"Chen Z, Jia X, Wang Z et al (2024) TRIB3 knockdown increases the sensitivity of clear cell renal cell carcinoma to sunitinib by inducing ferroptosis. Cell Signal 124:111421. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111421","journal-title":"Cell Signal"},{"key":"6709_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2025.117531","volume":"504","author":"Z Chen","year":"2025","unstructured":"Chen Z, Li W, Jia B et al (2025) Chrysin enhances sunitinib sensitivity in renal cell carcinoma by inducing ferroptosis via targeting PI3K\/Akt\/GPX4 pathway. Toxicol Appl Pharmacol 504:117531. https:\/\/doi.org\/10.1016\/j.taap.2025.117531","journal-title":"Toxicol Appl Pharmacol"},{"key":"6709_CR112","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41419-024-06732-4","volume":"15","author":"F Nejadi Orang","year":"2024","unstructured":"Nejadi Orang F, Abdoli Shadbad M (2024) Competing endogenous RNA networks and ferroptosis in cancer: novel therapeutic targets. Cell Death Dis 15:357. https:\/\/doi.org\/10.1038\/s41419-024-06732-4","journal-title":"Cell Death Dis"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06709-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06709-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06709-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T09:50:36Z","timestamp":1787133036000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06709-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":112,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6709"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06709-2","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Research involving human participants and\/or animals","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have reviewed and approved the final version of the manuscript and consent to its publication in this journal.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"587"}}